Bartlett & CO. Wealth Management LLC Trims Stake in MetLife, Inc. (NYSE:MET)

Bartlett & CO. Wealth Management LLC decreased its stake in shares of MetLife, Inc. (NYSE:METFree Report) by 1.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,209 shares of the financial services provider’s stock after selling 253 shares during the period. Bartlett & CO. Wealth Management LLC’s holdings in MetLife were worth $1,419,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. GoalVest Advisory LLC boosted its holdings in shares of MetLife by 73.3% in the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 165 shares during the last quarter. Wolff Wiese Magana LLC grew its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 277 shares during the period. Bank & Trust Co acquired a new stake in MetLife during the second quarter worth about $39,000. Crewe Advisors LLC lifted its stake in shares of MetLife by 602.5% in the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 482 shares in the last quarter. Finally, Larson Financial Group LLC grew its holdings in shares of MetLife by 72.6% during the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 239 shares during the period. 89.81% of the stock is owned by institutional investors and hedge funds.

MetLife Price Performance

MET opened at $85.32 on Friday. The company has a market capitalization of $60.67 billion, a P/E ratio of 29.32, a PEG ratio of 0.69 and a beta of 1.04. The company has a 50-day moving average of $78.52 and a 200-day moving average of $74.12. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 1-year low of $57.91 and a 1-year high of $86.94.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share for the quarter, beating the consensus estimate of $2.13 by $0.15. The firm had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. MetLife had a return on equity of 21.41% and a net margin of 4.23%. MetLife’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.94 earnings per share. Equities analysts expect that MetLife, Inc. will post 8.61 EPS for the current fiscal year.

MetLife Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be paid a $0.545 dividend. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a yield of 2.56%. MetLife’s payout ratio is currently 74.91%.

Analyst Ratings Changes

A number of brokerages have recently commented on MET. JPMorgan Chase & Co. raised their target price on shares of MetLife from $81.00 to $86.00 and gave the company an “overweight” rating in a research note on Tuesday, July 2nd. Morgan Stanley reduced their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research note on Friday, October 4th. TD Cowen began coverage on MetLife in a report on Wednesday, October 9th. They issued a “buy” rating and a $97.00 price target for the company. Finally, Piper Sandler boosted their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.46.

View Our Latest Research Report on MET

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.